Citrus Bergamot.

Both act on the mevalonate pathway at HMG-CoA reductase, so the effect on normal cholesterol handling stacks. Bergamot furanocoumarins also inhibit intestinal CYP3A4, which raises exposure to monacolin K, so the pairing needs conservative dosing rather than two full doses.

CoQ10 is made from the same mevalonate branch that bergamot polyphenols slow, so its own synthesis can fall when that pathway is damped. Supplying ubiquinol replaces what the pathway is no longer producing.

Endogenous CoQ10 shares the mevalonate precursor route with cholesterol, so damping that route lowers CoQ10 output too. Co-supplying it keeps mitochondrial electron transport supplied.

Berberine raises LDL receptor expression through PCSK9 and AMPK signalling while bergamot acts on the synthesis side at HMG-CoA reductase. Clearance and production are different levers on the same lipid pool.

Plant sterols compete with dietary cholesterol for micelle space in the gut, while bergamot works on the body's own synthesis. The two intercept different sources.

Artichoke supports bile flow, which draws cholesterol out through the bile acid route, a different exit than bergamot's effect on synthesis. Lipid formulas combine the two.

Omega-3 fatty acids act mainly on triglyceride production in the liver while bergamot polyphenols act on the cholesterol synthesis branch. They move different parts of the lipid panel.

Aged garlic supports vascular tone and normal blood pressure through hydrogen sulfide signalling, separate from bergamot's lipid pathway work. The two are conventional companions in heart formulas.

Oleuropein supports vascular tone and LDL particle oxidation resistance, a protective angle bergamot does not cover. Mediterranean polyphenol formulas pair them.

Bergamot flavanone glycosides are polar and poorly absorbed as free powder. Complexing the polyphenolic fraction with phospholipid produces a phytosome-type vehicle that has been the tested article in double-blind trials of this ingredient. The lecithin is a delivery matrix rather than a second active.

Phosphatidylcholine is the phospholipid that forms the polyphenol complex in phytosome preparations. The flavonoid hydrogen-bonds to the polar head group, which gives the assembly a lipophilic exterior that partitions into the enterocyte membrane more readily than the free glycoside. This is a formulation mechanism, measured as changed exposure rather than as a changed outcome.

Citrus flavanones and ascorbate occur together in the intact fruit and act on overlapping radical pools, with ascorbate able to regenerate flavonoid phenoxyl radicals in chemical systems. The pairing restores something of the food matrix that an isolated extract has lost. It supports normal antioxidant defence chemistry and is not an outcome claim.

Piperine inhibits intestinal UDP-glucuronosyltransferase and sulfotransferase activity, the two routes that conjugate absorbed flavonoid aglycones on first pass. Reducing that conjugation raises systemic exposure to the parent compounds. The effect is on how much circulates, which is a pharmacokinetic marker rather than a clinical result.

Quercetin and the bergamot flavanones are handled by the same phase II conjugation enzymes and the same efflux transporters. Co-dosing loads one clearance route with two substrates, which can raise the circulating share of each. Read it as a kinetic interaction, not as an added benefit.

Most ingested bergamot flavanone glycosides reach the colon intact, where bacterial glycosidases cleave the sugar before the aglycone can be absorbed. The same fermentation step generates short-chain fatty acids, which rose alongside bergamot polyphenol feeding in a rodent model. The microbial route is established biochemistry; the outcome part was measured in animals.

Colonic bacteria are the enzymes that release bergamot flavanone aglycones from their rhamnoglucoside sugars. A fermentable prebiotic supports the saccharolytic populations that carry out that hydrolysis. The link is mechanistic and has not been tested as a combination in people.

Soluble fibre binds bile acids in the small intestine and increases their faecal loss, which draws on hepatic cholesterol to replace them. Bergamot polyphenols act on lipid handling by a different route, so the two touch the same normal process from separate directions. Both are marker-level effects on blood lipids.

Citrus pectin comes from the same fruit peel that yields the polyphenolic fraction and is a viscous soluble fibre with a bile-acid binding action. In a combined formula the fibre works luminally while the flavonoids act after absorption. Both act on blood lipid readings, which are circulating markers rather than measured outcomes, and the pair has not been tested together.

A lecithin-formulated bergamot polyphenolic fraction reported movement in blood glucose readings as well as lipid readings in a double-blind trial. Chromium contributes to normal macronutrient metabolism through a separate mechanism. Anyone tracking blood sugar with both in a stack should expect the effects to sit on top of one another.

Catechins and citrus flavanones compete for the same glucuronidation and sulfation capacity and are effluxed by overlapping transporters. Stacking two concentrated polyphenol extracts changes the disposition of both. The interaction is kinetic and worth naming in a multi-polyphenol formula.

Silymarin flavonolignans and bergamot flavanones are both cleared largely by hepatic conjugation and both are used in formulas aimed at normal liver fat handling. One randomised trial of bergamot combined with wild cardoon, in adults without raised blood sugar, reported reduced liver fat imaging measures, and silymarin was not the partner in it. The pairing itself has no combination study behind it.

Lipoic acid cycles through the cellular thiol redox network that also regenerates oxidised polyphenols. Placing a flavonoid-rich extract in that network is chemically coherent. No trial of the two together is available, so the confidence stays at the bottom band.

Tocopherols work in the lipid phase and flavanone conjugates in the aqueous phase, and the two phases exchange radicals at the membrane interface. The combination covers both compartments. It is chemistry rather than a demonstrated joint effect.

Carnitine carries long-chain fatty acids across the inner mitochondrial membrane for beta-oxidation, while bergamot polyphenols reduced hepatic lipogenesis markers in a rodent study. One supports fat breakdown and one sits on fat synthesis, so they touch normal lipid handling from opposite ends. The animal data do not transfer to people on their own.

Proanthocyanidins and citrus flavanones are both polyphenol classes with overlapping conjugation and transport handling. Formulas often place them together for a broader polyphenol profile. There is no trial of this specific pair.